COVID-19: Off-Label Arzneimittel
COVID-19: Off-Label Arzneimittel Adenosin-Analogon BCX4430, Cobicistat, Darunavir, Favilavir, Favipiravir, Galidesivir, Hydroxychloroquin, Lopinavir - Kaletra®, Remdesivir, Ribavirin, Ritonavir - Kaletra®, Sarilumab - Kevzara®, Tocilizumab - Roactemra® (Auswahl ohne Gewähr)
Adenosin-Analogon BCX4430 - Arzneimittel - Cobicistat - Coronavirus - COVID-19 - Darunavir - Favilavir - Favipiravir - Galidesivir - Helferlein - Hydroxychloroquin - Lopinavir - Kaletra - monoklonale Antikörper - Off-Label-Use - Remdesivir - Ribavirin - Ritonavir - Kaletra - Sarilumab - Kevzara - Therapie - Tocilizumab - URL
